Table 3.
Flavanones with relevant GABAergic effects.
![]() Flavanone | ||
---|---|---|
Compound | Properties | Reference |
Naringenin (5,7,4’-O-trihydroxy) | Naringenin does not produce anxiolysis by modulation of the GABAARs but it does decrease motor movements. | [106] |
6-Prenylnaringenin | 6-Prenylnaringenin acts as a positive allosteric modulator at α+ β− binding interface as well as a null modulator at the flumazenil-sensitive α+ γ2− binding interface on GABAARs. | [107] |
8-Prenylnaringenin | 8-Prenylnaringenin potentiated GABA-induced displacement of [3H] ethynylbicycloorthobenzoate radioligand binding assay in native and recombinant α1β3γ2, α2β3γ2 and α6β3δ receptors (HEK293 cells, IC50 of 7.3 µM). | [108] |
Dihydromyricetin = ampelopsin (5,7,3’,4’,5’-O-tetrahydroxy) | Dihydromyricetin competitively inhibits the BZD-site [3H]-flunitrazepam binding site (IC50 4.36 μM), suggesting the interaction with the BZD sites on GABAAR. | [109] |
Dihydromyricetin prevents foetal alcohol exposure consequences in pregnant rats, avoiding the alterations in physiology, behaviour, and hippocampal GABAAR function. | [110] | |
Hesperidin (hesperetin 7-O-rutinoside) | Hesperidin possesses anticonvulsant activity which might be mediated through the modulation of GABA-BZD receptor action. | [111] |
The antihyperalgesic effect of hesperidin combined with diosmin involves central activity partially modulated by D2, GABAA, and opioid receptors, but not serotoninergic 5-HT1A receptors. | [112] | |
Kushenol I (3β,7,2’,4’-tetrahydroxy-5-methoxy-8-lavandulyl) (–)-Kurarinone (7,2’,4’-trihydroxy-5-methoxy-8-lavandulyl) Sophoraflavanone G (5,7,2’,4’-tetrahydroxy-8-lavandulyl) |
These flavanones act as GABAAR modulators. They induced the IGABA enhancement in Xenopus oocytes transiently expressing GABAAR with subunit composition: α1β2γ2S. EC50 are 5.0, 8.1 and 15.0 μM, respectively. | [113] |
Isoxanthohumol (7,4’-dihidroxy-5-methoxy-8-isoprenyl) | Isoxanthohumol potentiates GABA-induced displacement of [3H]-ethynylbicycloorthobenzoate radioligand binding assay in native and recombinant α1β3γ2, α2β3γ2 and α6β3δ receptors (HEK293 cells) in a concentration-dependent manner with an IC50 of 11.6 µM. | [108] |
Glycosides | ||
Eriocitrin (eriodictyol 7-O-rutinoside) (eriodictyol is 5,7,3’,4’-tetrahydroxy flavanone) |
The antinociceptive effect of eriocitrin is blocked by naltrexone (opioid receptor antagonist) and bicuculline (GABAAR antagonist). Therefore, the antinociception in postoperative pain conditions could be mediated through opioid and GABAARs. | [114] |